بدائل البحث:
significant event » significant effect (توسيع البحث), significant level (توسيع البحث), significant effects (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
event decrease » cement decreases (توسيع البحث), point decrease (توسيع البحث), levels decreased (توسيع البحث)
significant event » significant effect (توسيع البحث), significant level (توسيع البحث), significant effects (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
event decrease » cement decreases (توسيع البحث), point decrease (توسيع البحث), levels decreased (توسيع البحث)
-
1
-
2
-
3
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Study-related adverse events.
منشور في 2025"…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …"
-
12
Seven-day moving average number of PHC visits and health events during 2020.
منشور في 2025الموضوعات: -
13
-
14
-
15
Altered expression of genes related to Ca<sup>2+</sup> cycling or myocardial contraction.
منشور في 2025الموضوعات: -
16
-
17
-
18
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …"
-
19
-
20